Abiopharma

LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound

Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

Stepan Increases Quarterly Cash Dividend, Marking the 58th Consecutive Year of Increases

Axogen, Inc. Reports Third Quarter 2025 Financial Results

Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Stepan Reports Third Quarter 2025 Results

Bausch + Lomb Announces Third-Quarter 2025 Results

European Commission Approves KEYTRUDA® (pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CPS >1)

Immunic to Participate in Industry and Investor Conferences in November